PROPHASE LABS INC. - COMMON STOCK

ProPhase Labs Provides Update on Linebacker-1 Cancer Co-Therapy Program and Outlines Development Strategy

06 Feb 2023 08:00:01 By Nasdaq GlobeNewswire

ProPhase Labs Closes Acquisition of BE-Smart Esophageal Pre-Cancer Diagnostic Screening Test

05 Jan 2023 08:00:01 By Nasdaq GlobeNewswire

ProPhase Labs Acquires Rights to Novel Esophageal Cancer Test

19 Dec 2022 08:30:00 By Nasdaq GlobeNewswire

ProPhase Labs to Present at the Planet MicroCap Showcase: VIRTUAL 2022 on Wednesday, December 7, 2022

30 Nov 2022 08:00:01 By Nasdaq GlobeNewswire

ProPhase Labs Announces Record Third Quarter 2022 Financial Results

10 Nov 2022 08:00:04 By Nasdaq GlobeNewswire

ProPhase Labs Announces Collaboration with Dana-Farber Cancer Institute

08 Nov 2022 08:00:01 By Nasdaq GlobeNewswire

ProPhase Labs to Present at Investor Summit Group’s Q4 Conference

07 Nov 2022 19:12:00 By Nasdaq GlobeNewswire

ProPhase Labs to Host Third Quarter 2022 Financial Results Conference Call on Thursday, November 10, 2022 at 11:00 a.m. Eastern Time

04 Nov 2022 08:00:00 By Nasdaq GlobeNewswire

ProPhase Labs Announces Collaboration with G42 Healthcare

19 Oct 2022 08:00:02 By Nasdaq GlobeNewswire

ProPhase Labs to Present at The ThinkEquity Conference

18 Oct 2022 08:00:01 By Nasdaq GlobeNewswire

Nebula Genomics Strengthens Advisory Board with Appointment of Russ Altman, M.D., Ph.D.

17 Oct 2022 08:00:01 By Nasdaq GlobeNewswire

ProPhase Labs to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022 (HYBRID CONFERENCE)

06 Sep 2022 08:15:00 By Nasdaq GlobeNewswire

ProPhase Labs Announces Record Second Quarter 2022 Financial Results

11 Aug 2022 08:00:02 By Nasdaq GlobeNewswire

ProPhase Labs to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 11, 2022 at 11:00 a.m. Eastern Time

04 Aug 2022 20:33:00 By Nasdaq GlobeNewswire

ProPhase Labs Announces New $6 Million Stock Repurchase Plan

26 Jul 2022 08:00:02 By Nasdaq GlobeNewswire

ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

21 Jul 2022 18:00:00 By Nasdaq GlobeNewswire

ProPhase Labs Announces Licensing of New Investigational Cancer Compounds

21 Jul 2022 08:30:00 By Nasdaq GlobeNewswire

ProPhase Labs to Host Live Webcast to Discuss Business Developments on Thursday, July 21, 2022

19 Jul 2022 08:30:00 By Nasdaq GlobeNewswire

ProPhase Labs Announces Formation of ProPhase BioPharma, Inc. (PBIO) for the Licensing and Development of Novel Drugs, Compounds and Biotechnology

28 Jun 2022 08:30:00 By Nasdaq GlobeNewswire

ProPhase Labs Announces Significant Laboratory Expansion

13 Jun 2022 08:30:00 By Nasdaq GlobeNewswire